Biostem Technologies Inc (BSEM) earnings · P/E 8.5, rev $14.0M
Biostem Technologies Inc (BSEM) is a biotechnology company listed on US.
This BSEM earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BSEM revenue for 2026-06-30 was $14.0M. Net income was -$17.8M. Revenue was down 47.9% from 2025-06-30 to 2026-06-30. BSEM currently screens at market cap $211.2M and trailing P/E 8.5.
When the next BSEM 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 47.9% from 2025-06-30 to 2026-06-30. An earnings headline that ignores that move is noise.
Not investment advice. Full BSEM research stays on the stock page; the tape stays on the quote page.
Not investment advice.